Chinese University of Hong Kong

Scrip regularly reviews technology transfer activity across the biopharmaceutical sector. This edition of Tech Transfer Roundup focuses on oncology deals; the next edition will look at non-oncology de

The Sequenom affair may have dented expectations and stained credibility in the emerging field of noninvasive prenatal diagnostics, but the real question is whether any technology works yet. by Mark L

In Vitro Diagnostics Fluidigm Corp. Stanford University Fluidigm gets rights to Stanford University's prenatal IP Dec. — Fluidigm (technologies for genotyping, gene expression, and sequencing) has l

Mark L. Ratner There’s been a justifiable buzz around Sequenom Inc. ’s prenatal diagnostic technology and the anticipated launch next year of a blood-based test for fetal trisomy 21, or Down’s synd